| Document Date: 2014-06-12 07:31:17
Open Document File Size: 181,69 KBShare Result on Facebook
Company Boston Scientific / Sprint / / Country United States / Netherlands / Australia / / Currency USD / EUR / / Event Product Recall / Product Issues / FDA Phase / Reorganization / / Facility Electromechanical Therapy Institute / / IndustryTerm system technology / transvenous lead technologies / technology advancements / final device / higher energy outputs / media coverage / / MedicalCondition arrhythmia / ventricular tachycardia / ventricular dysfunction / sudden cardiac death / shock / pneumothorax / cardiovascular disease / bradycardia pacing / congenital thrombocytopenia / recurrent bacteremia positive / sudden cardiac arrest / myocardial infarction / B Strep Bacteremia / heart failure / nonischemic cardiomyopathy / endocarditis / bradycardia / ventricular fibrillation / systemic infections / infection / pocket infection / well-documented monomorphic ventricular tachycardia / syncopal episodes / systemic infection / acute renal failure / not require pacing for bradycardia / / MedicalTreatment drug therapy / / Organization Lung Center / Food and Drug Administration / Heart and Lung Center / Electromechanical Therapy Institute / Leiden University / FDA / / Person Wyatt Stahl / Deborah Heart / Raffaele Corbisiero / / Position Author / Director / experienced extractor / / Product ICD System / lead / lead failure rates / S-ICD System / / ProvinceOrState New Jersey / Vermont / Oregon / Michigan / / Technology transvenous ICD system technology / /
SocialTag |
EP LAB DIGEST June 2014 EP Review: The Subcutaneous ICD Author(s): Raffaele Corbisiero, MD, FACC1 and Wyatt Stahl, BSEE, 1Chair, Electrophysiology and Pacing and Director, Electromechanical Therapy Institute, Deborah Hea